Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease

This study has been completed.
Sponsor:
Information provided by:
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT00264524
First received: December 12, 2005
Last updated: November 26, 2010
Last verified: January 2004

December 12, 2005
November 26, 2010
January 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00264524 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
Not Provided

The current study was designed to determine whether the HLA-DRB1, DQA1, DQB1 alleles are associated with the risk and the pattern of valve damage of RHD.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Masking: Open Label
Primary Purpose: Diagnostic
Rheumatic Heart Disease
Procedure: venipuncture to withdraw patient's blood
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
July 2005
Not Provided

Inclusion Criteria:

  • 1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity

Exclusion Criteria:

-

Not Provided
Not Provided
Not Provided
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT00264524
CMU93-M-34
Not Provided
Not Provided
China Medical University Hospital
Not Provided
Principal Investigator: Hsiang-Tai Chou, MD, PhD China Medical University Hospital
China Medical University Hospital
January 2004

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP